Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan versus placebo after planned cardiac surgery in patients with severe left ventricular dysfunction
2019-001756-19Phase 4Terminated
- Sponsor
- MarÃa de los Ã�ngeles Tena Pajuelo (Investigador independiente)
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in heart failure (HF) and left ventricular systolic dysfunction (LVSD) comparing Simdax with Placebo (2 arms). Primary endpoints: Incidence of low cardiac output syndrome and Low cardiac output syndrome definition. Started Jan 2020; status: terminated.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on 2019-001756-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001756-19.